Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth ...

Shares of Hims & Hers Health (NYSE: HIMS) and LifeMD (NASDAQ: LFMD) are surging on Tuesday. Shares soared after pharma giant Novo Nordisk announced it will distribute its blockbuster GLP-1 weight loss ...

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...

Telehealth providers will soon offer more affordable access to weight loss drug Wegovy, according to manufacturer Novo ...

Novo Nordisk and a popular virtual health company are making Wegovy more accessible to millions of more Americans. Hims & ...

Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer, lower cost version of its popular weight-loss drug Wegovy. The pharmaceutical company announced it would ...

Hims & Hers Health partners with Novo Nordisk (NVO) to offer Wegovy, boosting weight-loss solutions. See why I remain ...

Currently Wegovy has a list price of around $1,350 for a 28-day supply. This means that the medication could cost more than ...

In essence, Hims & Hers is embracing a "if you can't beat 'em, join 'em" approach that gives their customers more options.

A grandma of 11 and a New Jersey man have joined the growing chorus of users of the wildly popular weight-loss drugs Ozempic ...

A batch of the drug is under a limited voluntary recall after a shipping error exposed certain doses to improper temperatures.

Deals with Hims & Hers, LifeMD and Ro following a court's dismissal of a lawsuit challenging the FDA's determination Wegovy ...